Landos collaborates with Johns Hopkins to further validate NLRX1 immunometabolic pathway in MS Aug. 27, 2021
Vyant Bio to collaborate with Cyclica on discovery of treatments for CDKL5 deficiency disorder Aug. 20, 2021
VYNE and In4Derm enter licence agreement for discovery and development of BET inhibitor platform Aug. 13, 2021